THE HOBBS GROUP, LLC for JOHNSON & JOHNSON
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Proposed CMS national coverage decisions for the use to erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HOBBS | Assistant to the President for Legislative Affairs |
Medicare/Medicaid MMM
Proposed CMS national coverage decisions for the use to erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HOBBS | Assistant to the President for Legislative Affairs |
Taxation/Internal Revenue Code TAX
H.R.2138, The Investment in America Act of 2007; S.41, The Research Competitiveness Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HOBBS | Assistant to the President for Legislative Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.